We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
P
301
Pitcairn
Pennsylvania
$249K +$230K +3,119 New
BSW
302
Buckingham Strategic Wealth
Missouri
$244K +$225K +3,050 New
PPSG
303
Princeton Portfolio Strategies Group
New Jersey
$242K +$223K +3,025 New
PPCM
304
Pillar Pacific Capital Management
California
$240K +$221K +3,000 New
WAM
305
Wolverine Asset Management
Illinois
$237K +$218K +2,965 New
SI
306
Stephens Inc
Arkansas
$234K +$215K +2,920 New
NIM
307
NuWave Investment Management
New Jersey
$232K +$213K +2,892 New
YMRC
308
Yorktown Management & Research Company
Virginia
$232K +$214K +2,900 New
WSTAM
309
Wilbanks Smith & Thomas Asset Management
Virginia
$229K +$211K +2,862 New
WCA
310
Westover Capital Advisors
Delaware
$208K +$191K +2,594 New
BF
311
BOK Financial
Oklahoma
$205K +$189K +2,561 New
LI
312
LMCG Investments
Massachusetts
$205K +$189K +2,561 New
Teacher Retirement System of Texas
313
Teacher Retirement System of Texas
Texas
$202K +$186K +2,528 New
LTFS
314
Ladenburg Thalmann Financial Services
Florida
$177K +$160K +2,177 New
OA
315
OFI Advisors
Pennsylvania
$157K +$145K +1,965 New
BBHC
316
Brown Brothers Harriman & Co
New York
$134K +$123K +1,670 New
Robeco Institutional Asset Management
317
Robeco Institutional Asset Management
Netherlands
$104K +$96.3K +1,307 New
SAMC
318
Shinko Asset Management Company
Japan
$88K +$81K +1,100 New
MUMSS
319
Mitsubishi UFJ Morgan Stanley Securities
Japan
$85K +$78.1K +1,060 New
NES
320
New England Securities
New York
$76K +$69.7K +947 New
WIL
321
Winifred I. Li
$72K +$66.3K +900 New
Creative Planning
322
Creative Planning
Kansas
$70K +$64.1K +870 New
TSWM
323
Triangle Securities Wealth Management
North Carolina
$68K +$62.6K +850 New
Fifth Third Bancorp
324
Fifth Third Bancorp
Ohio
$63K +$58.3K +791 New
PTC
325
Private Trust Company
Ohio
$62K +$56.8K +771 New
11 12
13
14 15

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.